TrialCancer research and treatment2024
Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials.
Youjin Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.